Home / Departments & Kliniken / Universitätskliniken / Universitätsklinik für Innere Medizin / Publikationen
Universitätsklinik für Innere Medizin

Publikationen

  1. 2021

    • Zeitschriftenartikel

      • Angleitner, P., Schloglhofer, T., Wiedemann, D., Riebandt, J., Strassl, A., Mascherbauer, J., Kainz, M., Laufer, G., Zuckermann, A. & Zimpfer, D., 2021. The HeartMate 6 and CardioMEMS for Fixed Pulmonary Hypertension. ASAIO journal.

      • Aringer, I., Artinger, K., Schabhüttl, C., Bärnthaler, T., Mooslechner, A.A., Kirsch, A., Pollheimer, M., Eller, P., Rosenkranz, A.R., Heinemann, A. & Eller, K., 2021. Agonism of Prostaglandin E2 Receptor 4 Ameliorates Tubulointerstitial Injury in Nephrotoxic Serum Nephritis in Mice. Journal of clinical medicine, 10(4).

      • Auer, J. & Lamm, G., 2021. Haemoglobin drop with and without bleeding in patients with acute coronary syndromes. European journal of clinical investigation, S.e13675.

      • Auer, J. & Lamm, G., 2021. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. The New England journal of medicine, 385(11), S.1053.

      • Auer, J. & Lamm, G., 2021. The role of aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease. European journal of preventive cardiology.

      • Bartko, P.E., Heitzinger, G., Pavo, N., Heitzinger, M., Spinka, G., Prausmüller, S., Arfsten, H., Andreas, M., Gabler, C., Strunk, G., Mascherbauer, J., Hengstenberg, C., Hulsmann, M. & Goliasch, G., 2021. Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ (Clinical research ed.), 373, S.n1421.

      • Behr, J., Gunther, A., Bonella, F., Dinkel, J., Fink, L., Geiser, T., Geissler, K., Glaser, S., Handzhiev, S., Jonigk, D., Koschel, D., Kreuter, M., Leuschner, G., Markart, P., Prasse, A., Schonfeld, N., Schupp, J.C., Sitter, H., Muller-Quernheim, J. & Costabel, U., 2021. S2K Guideline for Diagnosis of Idiopathic Pulmonary Fibrosis. Respiration.

      • Blackman, D., Gabbieri, D., Del Blanco, B.García, Kempfert, J., Laine, M., Mascherbauer, J., Parma, R. & Tchétché, D., 2021. Expert Consensus on Sizing and Positioning of SAPIEN 3/Ultra in Bicuspid Aortic Valves. Cardiology and therapy.

      • Borovac, J.A., Leth-Olsen, M., Kumric, M., D'Amario, D., Schwarz, K., Glavas, D. & Bozic, J., 2021. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence. European journal of clinical pharmacology.

      • Buder, A., Heitzer, E., Waldispühl-Geigl, J., Weber, S., Moser, T., Hochmair, M.J., Hackner, K., Errhalt, P., Setinek, U. & Filipits, M., 2021. Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients. Biomolecules, 11(5).

      • Chair, O.A.Smiseth, Morris, D.A., Cardim, N., Cikes, M., Delgado, V., Donal, E., Flachskampf, F.A., Galderisi, M., Gerber, B.L., Gimelli, A., Klein, A.L., Knuuti, J., Lancellotti, P., Mascherbauer, J., Milicic, D., Seferovic, P., Solomon, S., Edvardsen, T. & Co-Chair, B.A.Popescu, 2021. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging. European heart journal. Cardiovascular Imaging, S.jeab154.

      • Dannenberg, V., Christiansen, F., Schneider, M., Kastl, S., Hofbauer, T.Martin, Scherz, T., Mascherbauer, J., Beitzke, D., Testori, C., Lang, I.Marthe & Mangold, A., 2021. Exploratory echocardiographic strain parameters for the estimation of myocardial infarct size in ST-elevation myocardial infarction. Clinical cardiology.

      • Fan, F. & Podar, K., 2021. The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology. Cancers, 13(10), S.2326.

      • Fan, F., Malvestiti, S., Vallet, S., Lind, J., Garcia-Manteiga, J.Manuel, Morelli, E., Jiang, Q., Seckinger, A., Hose, D., Goldschmidt, H., Stadlbauer, A., Sun, C., Mei, H., Pecherstorfer, M., Bakiri, L., Wagner, E.F., Tonon, G., Sattler, M., Hu, Y., Tassone, P., Jaeger, D. & Podar, K., 2021. JunB is a key regulator of multiple myeloma bone marrow angiogenesis. Leukemia.

      • Gerges, C., Friewald, R., Gerges, M., Shafran, I., Sadushi-Koliçi, R., Skoro-Sajer, N., Moser, B., Taghavi, S., Klepetko, W. & Lang, I.M., 2021. Efficacy and Safety of Percutaneous Pulmonary Artery Subtotal Occlusion and Chronic Total Occlusion Intervention in Chronic Thromboembolic Pulmonary Hypertension. Circulation. Cardiovascular interventions.

      • Hackner, K., Buder, A., Hochmair, M.J., Strieder, M., Grech, C., Fabikan, H., Burghuber, O.C., Errhalt, P. & Filipits, M., 2021. Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients. Clinical Medicine Insights: Oncology, 15, S.1179554921993072.

      • Hasun, M., Dörler, J., Alber, H.F., Bauer, A., Berger, R., Christ, G., Frick, M., Hoppe, U.C., Huber, K., Lamm, G., Laßnig, E., von Lewinski, D., Rab, A., Roithinger, F.X., Schuchlenz, H., Siostrzonek, P., Sipötz, J., Stefenelli, T., Steinwender, C., Edlinger, M. & Weidinger, F., 2021. Improved in-hospital outcome for radial access in a large contemporary cohort of primary percutaneous coronary intervention. Cardiovascular diagnosis and therapy, 11(3), S.726-735.

      • Höbaus, C., Ursli, M., Yussef, S.Mohammed, Wrba, T., Koppensteiner, R. & Schernthaner, G.-H., 2021. Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes. Vascular medicine, S.1358863X20982077.

      • Huber, F., Zwickl-Traxler, E., Pecherstorfer, M. & Singer, J., 2021. Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma—A Single-Center Retrospective Cohort Study. Current Oncology, 28(6), S.4521-4529.

      • John, L., Krauth, M.Theresa, Podar, K. & Raab, M.-S., 2021. Pathway-Directed Therapy in Multiple Myeloma. Cancers, 13(7), S.1668.

      • Kammerlander, A.A., Nitsche, C., Dona, C., Koschutnik, M., Dannenberg, V., Mascherbauer, K., Schönbauer, R., Zafar, A., Winter, M.-P., Bartko, P.E., Goliasch, G., Hengstenberg, C. & Mascherbauer, J., 2021. Heart Failure with Preserved Ejection Fraction after Left-sided Valve Surgery: Prevalent and Relevant. European journal of heart failure.

      • Keepanasseril, A., Pfaller, B., Metcalfe, A., Siu, S.C., Davis, M.B. & Silversides, C.K., 2021. Cardiovascular Deaths in Pregnancy: Growing Concerns and Preventive Strategies. The Canadian journal of cardiology, S.S0828-282X(21)00743-1.

      • Kornauth, C., Pemovska, T., Vladimer, G.I., Bayer, G., Bergmann, M., Eder, S., Eichner, R., Erl, M., Esterbauer, H., Exner, R., Felsleitner-Hauer, V., Forte, M., Gaiger, A., Geissler, K., Greinix, H.T., Gstöttner, W., Hacker, M., Hartmann, B.Lorenz, Hauswirth, A.W., Heinemann, T., Heintel, D., Hoda, M.Alireza, Hopfinger, G., Jaeger, U., Kazianka, L., Kenner, L., Kiesewetter, B., Krall, N., Krajnik, G., Kubicek, S., Le, T., Lubowitzki, S., Mayerhoefer, M.E., Menschel, E., Merkel, O., Miura, K., Müllauer, L., Neumeister, P., Noesslinger, T., Ocko, K., Öhler, L., Panny, M., Pichler, A., Porpaczy, E., Prager, G.W., Raderer, M., Ristl, R., Ruckser, R., Salamon, J., Schiefer, A.-I., Schmolke, A.-S., Schwarzinger, I., Selzer, E., Sillaber, C., Skrabs, C., Sperr, W.R., Srndic, I., Thalhammer, R., Valent, P., van der Kouwe, E., Vanura, K., Vogt, S., Waldstein, C., Wolf, D., Zielinski, C.C., Zojer, N., Simonitsch-Klupp, I., Superti-Furga, G., Snijder, B. & Staber, P.B., 2021. Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematological Cancers and Identifies Exceptional Responders. Cancer Discovery.

      • Lamm, G., 2021. New strategies in the management of valvular heart disease : A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease. Wiener klinische Wochenschrift.

      • Lamm, G., Hammerer, M., Hoppe, U.C., Andreas, M., Berger, R., Binder, R.K., Bonaros, N., Delle-Karth, G., Frick, M., Grund, M., Metzler, B., Neunteufl, T., Pichler, P., Schmidt, A., Wisser, W., Zierer, A., Seitelberger, R., Grimm, M., Geppert, A., Okg, & Oghtg, 2021. 2020 update of the Austrian Society of Cardiology (OKG) and the Austrian Society of Cardiac Surgery (OGHTG) on the position statement of the OKG and OGHTG for transcatheter aortic valve implantation 2011. Wiener klinische Wochenschrift.

      • Lang, D., Moazedi-Fürst, F., Sautner, J., Prosch, H., Handzhiev, S., Hackner, K., Tancevski, I., Flick, H., Koller, H., Kiener, H.Peter, Prior, C. & Lamprecht, B., 2021. Consensus-Statement der Österreichischen Gesellschaften für Pneumologie und Rheumatologie zur Definition, Evaluation und Therapie von progredient fibrosierenden interstitiellen Lungenerkrankungen (pfILD). Wiener klinische Wochenschrift.

      • Lapidot, M., Case, A.E., Weisberg, E.L., Meng, C., Walker, S.R., Garg, S., Ni, W., Podar, K., Hung, Y.P., Carrasco, R.D., Knott, A., Gokhale, P.C., Sharma, S., Pozhitkov, A., Kulkarni, P., Frank, D.A., Salgia, R., Griffin, J.D., Saladi, S.V., Bueno, R. & Sattler, M., 2021. Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM). British journal of cancer.

      • Martinek, M., Manninger, M., Schönbauer, R., Scherr, D., Schukro, C., Pürerfellner, H., Petzl, A., Strohmer, B., Derndorfer, M., Bisping, E., Stühlinger, M. & Fiedler, L., 2021. Expert consensus on acute management of ventricular arrhythmias - VT network Austria. International journal of cardiology. Heart & vasculature, 34, S.100760.

      • Merseburger, A.S., Geiges, G., Klier, J., Wiesholzer, M. & Pichler, P., 2021. Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting. Frontiers in oncology, 11, S.655355.

      • Niespodziana, K., Stenberg-Hammar, K., Papadopoulos, N.G., Focke-Tejkl, M., Errhalt, P., Konradsen, J.R., Söderhall, C., van Hage, M., Hedlin, G. & Valenta, R., 2021. Microarray Technology May Reveal the Contribution of Allergen Exposure and Rhinovirus Infections as Possible Triggers for Acute Wheezing Attacks in Preschool Children. Viruses, 13(5), S.915.

      • Nitsche, C., Kammerlander, A.A., Koschutnik, M., Sinnhuber, L., Forutan, N., Eidenberger, A., Dona, C., Schartmueller, F., Dannenberg, V., Winter, M.-P., Siller-Matula, J., Anvari-Pirsch, A., Goliasch, G., Hengstenberg, C. & Mascherbauer, J., 2021. Fluid overload in patients undergoing TAVR: what we can learn from the nephrologists. ESC heart failure.

      • Odler, B., Windpessl, M., Krall, M., Steiner, M., Riedl, R., Hebesberger, C., Ursli, M., Zitt, E., Lhotta, K., Antlanger, M., Cejka, D., Gauckler, P., Wiesholzer, M., Saemann, M., Rosenkranz, A.R., Eller, K. & Kronbichler, A., 2021. The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis. Frontiers in Immunology, 12, S.760708.

      • Pavo, N., Prausmüller, S., Spinka, G., Goliasch, G., Bartko, P.E., Wurm, R., Arfsten, H., Strunk, G., Poglitsch, M., Domenig, O., Mascherbauer, J., Uyanik-Ünal, K., Hengstenberg, C., Zuckermann, A. & Hulsmann, M., 2021. Myocardial Angiotensin Metabolism in End-Stage Heart Failure. Journal of the American College of Cardiology, 77(14), S.1731-1743.

      • Pfaller, B., Bendien, S., Ditisheim, A. & Eiwegger, T., 2021. Management of allergic diseases in pregnancy. Allergy.

      • Pfaller, B., Javier, A.Dave, Grewal, J., Gabarin, N., Colman, J., Kiess, M., Wald, R.M., Sermer, M., Siu, S.C. & Silversides, C.K., 2021. Risk Associated With Valvular Regurgitation During Pregnancy. Journal of the American College of Cardiology, 77(21), S.2656-2664.

      • Pfaller, B., Siu, S.C., D'Souza, R., Wichert-Schmitt, B., Nair, G.Krishna Ku, Haberer, K., Maxwell, C. & Silversides, C.K., 2021. Impact of Obesity on Outcomes of Pregnancy in Women With Heart Disease. Journal of the American College of Cardiology, 77(10).

      • Podar, K. & Leleu, X., 2021. Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond. Cancers, 13(20), S.5154.

      • Poole, J.E., Swerdlow, C.D., Tarakji, K.G., Mittal, S., Ellenbogen, K.A., Greenspon, A.J., Kennergren, C., Philbert, B.T., Moore, J., Jones, R.C., Schaller, R.D., Hansalia, R., Simmers, T., Mihalcz, A., DeBus, B., Lexcen, D.R., Gunderson, B. & Wilkoff, B.L., 2021. Clinical Performance of Implantable Cardioverter Defibrillator Lead Monitoring Diagnostics. Heart Rhythm.

      • Pozzi, S., Bari, A., Pecherstorfer, M. & Vallet, S., 2021. Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma. Cancers, 13(19), S.4978.

      • Scharrer, S., Primas, C., Eichinger, S., Tonko, S., Kutschera, M., Koch, R., Blesl, A., Reinisch, W., Mayer, A., Haas, T., Feichtenschlager, T., Fuchssteiner, H., Steiner, P., Ludwiczek, O., Platzer, R., Miehsler, W., Tillinger, W., Apostol, S., Schmid, A., Schweiger, K., Vogelsang, H., Dejaco, C., Herkner, H. & Novacek, G., 2021. Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism. Inflammatory bowel diseases.

      • Schöls, K., 2021. Wenn der Schnupfen lebensgefährlich wird. rheuma plus.

      • Schwarz, K., Lovatt, S., Borovac, J.A., Parasuraman, S. & Kwok, C.Shing, 2021. Planned versus bailout rotational atherectomy: A systematic review and meta-analysis. Cardiovascular Revascularization Medicine.

      • Semmler, G., Barbieri, F., Thudt, K., Vock, P., Moertl, D., Mayr, H., Wollmann, C.Georg, Adukauskaite, A., Pfeifer, B., Senoner, T. & Dichtl, W., 2021. Long-Term Technical Performance of the Osypka QT-5((R)) Ventricular Pacemaker Lead. Journal of clinical medicine, 10(4).

      • Singer, J., Brauneck, E., Zwickl-Traxler, E. & Pecherstorfer, M., 2021. Evaluation of personalized cancer therapies based on comprehensive genomic profiling in a middle-sized oncologic center in Austria, the University Clinic Krems. Translational oncology, 14(5), S.101021.

      • Singer, J., Le, N.-S., Mattes, D., Klamminger, V., Hackner, K., Kolinsky, N., Scherb, M., Errhalt, P., Kreye, G., Pecherstorfer, M., Vallet, S. & Podar, K., 2021. Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients. Cancers, 13(17).

      • Stadlbauer, A., Kinfe, T.M., Eyupoglu, I., Zimmermann, M., Kitzwögerer, M., Podar, K., Buchfelder, M., Heinz, G., Oberndorfer, S. & Marhold, F., 2021. Tissue hypoxia and alterations in microvascular architecture predict glioblastoma recurrence in humans. Clinical cancer research : an official journal of the American Association for Cancer Research.

      • Steiner, E., Mayer, A. & Maieron, A., 2021. Motorized spiral enteroscopy - when things happen: troubleshooting spiral disconnection at 90 minutes into the enteroscopic procedure. Endoscopy.

      • Tremblay, G., Daniele, P., Breeze, J., Li, L., Shah, J., Shacham, S., Kauffman, M., Engelhardt, M., Chari, A., Nooka, A., Vogl, D., Gavriatopoulou, M., Dimopoulos, M.-A., Richardson, P., Biran, N., Siegel, D., Vlummens, P., Doyen, C., Facon, T., Mohty, M., Meuleman, N., Levy, M., Costa, L., Hoffman, J.E., Delforge, M., Kaminetzky, D., Weisel, K., Raab, M., Dingli, D., Tuchman, S., Laurent, F., Vij, R., Schiller, G., Moreau, P., Richter, J., Schreder, M., Podar, K., Parker, T., Cornell, R.Frank, Lionel, K., Choquet, S. & Sundar, J., 2021. Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study. BMC Cancer, 21(1), S.993.

      • Untersmayr, E., Förster-Waldl, E., Bonelli, M., Boztug, K., Brunner, P.M., Eiwegger, T., Eller, K., Göschl, L., Grabmeier-Pfistershammer, K., Hötzenecker, W., Jordakieva, G., Moschen, A.R., Pfaller, B., Pickl, W., Reinisch, W., Wiedermann, U., Klimek, L., Bergmann, K.-C., Brehler, R., Pfutzner, W., Novak, N., Merk, H., Rabe, U., Schlenter, W., Ring, J., Wehrmann, W., Mülleneisen, N., Wrede, H., Fuchs, T. & Jensen-Jarolim, E., 2021. Immunologically relevant aspects of the new COVID-19 vaccines-an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper. Allergo journal international, S.1-14.

      • Vamvakidou, A., Annabi, M.-S., Pibarot, P., Plonska-Gosciniak, E., Almeida, A.G., Guzzetti, E., Dahou, A., Burwash, I.G., Koschutnik, M., Bartko, P.E., Bergler-Klein, J., Mascherbauer, J., Orwat, S., Baumgartner, H., Cavalcante, J., Pinto, F., Kukulski, T., Kasprzak, J.D., Clavel, M.-A., Flachskampf, F.A. & Senior, R., 2021. Clinical Value of Stress Transaortic Flow Rate During Dobutamine Echocardiography in Reduced Left Ventricular Ejection Fraction, Low-Gradient Aortic Stenosis: A Multicenter Study. Circulation. Cardiovascular imaging, S.Circimaging121012809.

      • Van den Nest, M., Wagner, G., Riesenhuber, M., Dolle, C., Presterl, E., Gartlehner, G., Moertl, D. & Willinger, B., 2021. Filamentous Fungal Infections in a Tertiary Care Setting: Epidemiology and Clinical Outcome. Journal of Fungi, 7(1).

      • Wagner, G., Moertl, D., Glechner, A., Mayr, V., Klerings, I., Zachariah, C., Van den Nest, M., Gartlehner, G. & Willinger, B., 2021. Paracoccidioidomycosis Diagnosed in Europe-A Systematic Literature Review. Journal of Fungi, 7(2).

      • Wichert-Schmitt, B., Steckham, K.Elizabeth, Pfaller, B., Colman, J.Marc, Wald, R.Maya, Sermer, M., Mason, J., Siu, S.Chi Bun & Silversides, C.Kristeen, 2021. Cardiac Complications in Pregnant Women With Isolated Mitral Stenosis and Their Association With Echocardiographic Changes During Pregnancy. The American journal of cardiology, S.S0002-9149(21)00723-2 [pii].

      • Will, M. & Mascherbauer, J., 2021. Patient engagement in cardiology-nice or necessary?. Wiener klinische Wochenschrift, 133(15-16), S.747-749.

      • Will, M., Kwok, C.Shing, Nagaraja, V., Potluri, R., Weiss, T.W., Mascherbauer, J. & Schwarz, K., 2021. Outcomes of patients who undergo elective covered stent treatment for coronary artery aneurysms. Cardiovascular revascularization medicine : including molecular interventions, S.S1553-8389(21)00264-5 [pii].

      • Zwickl, H., Zwickl-Traxler, E., Haushofer, A., Seier, J., Podar, K., Weber, M., Hackner, K., Jacobi, N., Pecherstorfer, M. & Vallet, S., 2021. Effect of cachexia on bone turnover in cancer patients: a case-control study. BMC Cancer, 21(1), S.744.

    • Konferenzbeitrag

      • Aksoy, O., Lind, J., Sunder-Plassmann, V., Pecherstorfer, M., Vallet, S. & Podar, K., 2021. Poster: P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies. In 18th International Myeloma Workshop. 08.-11.09.2021. Vienna, Austria, S. S83-S84.

      • Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E.F., Sattler, M., Pecherstorfer, M. & Podar, K., 2021. Poster: Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy – Update. In OeGHO Frühjahrstagung. 8.-10.4.2021. Online, S. 23-41.

      • Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Zwickl-Traxler, E., Fan, F., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E., Sattler, M., Pecherstorfer, M. & Podar, K., 2021. Presentation: OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity. In 18th International Myeloma Workshop. 08.-11.09.2021. Vienna, Austria, S. S19-S20.

      • Ludwig, H., Melchardt, T., Sormann, S., Schreder, M., Andel, J., Hartmann, B., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Woll, E., Zojer, N., Ruckser, R., Bozic, B., Krauth, M.Theresa, Petzer, A., Schmitt, C.A., Machherndl-Spandl, S., Agis, H., Fillitz, M., Pönisch, W., Knop, S., Paiva, B. & Greil, R., 2021. Poster: Time to best response correlates with outcome in the randomized comparison between KRD and KTD followed by K maintenance or observation (AGMT-MM02 TRIAL). In EHA 2021 Virtual Congress. 9.-17.6.2021. Online, S. 325729; EP971.

    • Andere wissenschaftliche Beiträge

      • Podar, K., 2021. Highlights beim Multiplen Myelom. krebs:hilfe!, (2), S.42-43.

  2. 2020

    • Zeitschriftenartikel

      • Anwar, M., Fritze, R., Base, E., Wasserscheid, T., Wolfram, N., Koinig, H., Hackner, K., Lambers, C., Schweiger, T., Errhalt, P. & Hoda, M.A., 2020. Infraglottic versus supraglottic jet-ventilation for endobronchial ultrasound-guided transbronchial needle aspiration: A randomised controlled trial. European journal of anaesthesiology.

      • Auer, J. & Lamm, G., 2020. Ticagrelor with or without Aspirin after PCI. The New England journal of medicine, 382(11), S.1075-1076.

      • Behr, J., Gunther, A., Bonella, F., Dinkel, J., Fink, L., Geiser, T., Geissler, K., Glaser, S., Handzhiev, S., Jonigk, D., Koschel, D., Kreuter, M., Leuschner, G., Markart, P., Prasse, A., Schonfeld, N., Schupp, J.C., Sitter, H., Muller-Quernheim, J. & Costabel, U., 2020. S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose. Pneumologie.

      • Bruestle, K., Hackner, K., Kreye, G. & Heidecker, B., 2020. Autoimmunity in Acute Myocarditis: How Immunopathogenesis Steers New Directions for Diagnosis and Treatment. Current cardiology reports, 22(5), S.28.

      • Burghuber, O.C., Kirchbacher, K., Mohn-Staudner, A., Hochmair, M., Breyer, M.-K., Studnicka, M., Mueller, M.Rolf, Feurstein, P., Schrott, A., Lamprecht, B., Eckmayr, J., Renner, F., Bolitschek, J., Pohl, W., Schenk, P., Errhalt, P., Cerkl, P., Baumgartner, B., Kneussl, M. & Hartl, S., 2020. Results of the Austrian National Lung Cancer Audit. Clinical Medicine Insights. Oncology, 14, S.1179554920950548.

      • Fastner, G., Sedlmayer, F., Widder, J., Metz, M., Geinitz, H., Kapp, K., Fesl, C., Solkner, L., Greil, R., Jakesz, R., Kwasny, W., Heck, D., Bjelic-Radisic, V., Balic, M., Stoger, H., Wieder, U., Zwrtek, R., Semmler, D., Horvath, W., Melbinger-Zeinitzer, E., Wiesholzer, M., Wette, V. & Gnant, M., 2020. Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial. European journal of cancer, 127, S.12-20.

      • Fazekas-Singer, J., Singer, J. & Jensen-Jarolim, E., 2020. Precision medicine in clinical oncology: the journey from IgG antibody to IgE. Current opinion in allergy and clinical immunology, 20(3), S.282-289.

      • Flick, H., Arns, B.-M., Bolitschek, J., Bucher, B., Cima, K., Gingrich, E., Handzhiev, S., Hochmair, M., Horak, F., Idzko, M., Jaksch, P., Kovacs, G., Kropfmüller, R., Lamprecht, B., Löffler-Ragg, J., Meilinger, M., Olschewski, H., Pfleger, A., Puchner, B., Puelacher, C., Prior, C., Rodriguez, P., Salzer, H., Schenk, P., Schindler, O., Stelzmüller, I., Strenger, V., Täubl, H., Urban, M., Wagner, M., Wimberger, F., Zacharasiewicz, A., Zwick, R.Harun & Eber, E., 2020. Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP). Wiener klinische Wochenschrift.

      • Gelbenegger, G., Schoergenhofer, C., Derhaschnig, U., Buchtele, N., Sillaber, C., Fillitz, M., Schenk, T.M., D'Sa, S., Cartwright, R., Gilbert, J.C., Jilma, B. & Jaeger, U., 2020. Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program. Blood advances, 4(6), S.997-1005.

      • Ghanim, B., Rosenmayr, A., Stockhammer, P., Vogl, M., Celik, A., Bas, A., Kurul, I.Cuneyt, Akyurek, N., Varga, A., Plönes, T., Bankfalvi, A., Hager, T., Schuler, M., Hackner, K., Errhalt, P., Scheed, A., Seebacher, G., Hegedus, B., Stubenberger, E. & Aigner, C., 2020. Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition. Scientific Reports, 10(1), S.5784.

      • Hackner, K., Errhalt, P., Willheim, M., Schragel, F., Grasl, M.-A., Lagumdzija, J., Riegler, W., Ecker, M., Wechdorn, M., Thalhammer, F. & Assadian, O., 2020. Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population. GMS Hygiene and Infection Control, 15, S.Doc28.

      • Hochmair, M.J., Fabikan, H., Illini, O., Weinlinger, C., Setinek, U., Krenbek, D., Prosch, H., Rauter, M., Schumacher, M., Woll, E., Wass, R., Brehm, E., Absenger, G., Bundalo, T., Errhalt, P., Urban, M. & Valipour, A., 2020. Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis. Pharmaceuticals, 13(11).

      • Jäger, E.Maria, Filipits, M., Glechner, A., Zwickl-Traxler, E., Schmoranzer, G., Pecherstorfer, M. & Kreye, G., 2020. Retrospective analysis of the prevalence of specialised palliative care services for patients with metastatic breast cancer. ESMO open, 5(5).

      • Kleinsasser, A., Treml, B., Burtscher, J., Podolsky, A. & Burtscher, M., 2020. Oxygen availability in a HAPE-positive and a HAPE-negative woman before and during a visit to 3480 meters. Respiratory physiology & neurobiology, S.103513.

      • Klösch, M., Deix, G. & von Reibnitz, C., 2020. Nähe vermitteln in Zeiten der Distanz: Digitale Angebote fur Trauerfeiern und Bestattungen unter COVID-19-Bedingungen. Procare : das fortbildungsmagazin fur pflegeberufe, 25(4), S.14-16.

      • Krall, N., Sehlke, R., Taubert, C., Alt, I., Rohrer, F., Fuchs, E., Vilagos, B., Schumacher, M., Maurer, D., Hackner, K., Lafleur, J., Hefler, L., Minichsdorfer, C., Fuereder, T. & Vladimer, G., 2020. Towards patient-centric drug discovery: Drug action in malignant pleural effusions and ascites using high content imaging and deep learning. Journal of Clinical Oncology, 38, S.e21633-e21633.

      • Kreye, G., Heidecker, B. & Masel, E.K., 2020. The top ten things that must be known about end of life therapy in patients with advanced cancer. memo - Magazine of European Medical Oncology, 13(1), S.88-92.

      • Kutschera, M., Waldhor, T., Grochenig, H.Peter, Haas, T., Wenzl, H., Steiner, P., Koch, R., Feichtenschlager, T., Eckhardt, G., Mayer, A., Kirchgatterer, A., Ludwiczek, O., Platzer, R., Papay, P., Gartner, J., Fuchssteiner, H., Peters, P.-G., Reicht, G., Moser, G., Dejaco, C., Vogelsang, H., Primas, C., Novacek, G. & Miehsler, W., 2020. Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease. United European gastroenterology journal, S.2050640620946874.

      • Lapidot, M., Case, A.E., Larios, D., Gandler, H.I., Meng, C., Tosic, I., Weisberg, E.L., Poitras, M.J., Gokhale, P.C., Paweletz, C.P., Podar, K., Salgia, R., Saladi, S.V., Griffin, J.D., Frank, D.A., Bueno, R. & Sattler, M., 2020. Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM). Cancers, 13(1).

      • Manrique, I., Greil, R., Andel, J., Sormann, S., Hartmann, B.L., Podar, K., Egle, A., Petzer, A., Zojer, N., Ruckser, R., Bozic, B., Schmitt, C.A., Machherndl-Spandl, S., Agis, H., Schreder, M., Krauth, M.-T., Tinchon, C., Fillitz, M., Melchardt, T., Paiva, B. & Ludwig, H., 2020. Immunophenotyping of Baseline Bone Marrow Reveals a Specific Pattern of Immune Cells Associated with Greater Depth and Sustained Response in Newly Diagnosed Patients Randomized to Krd or Ktd Followed By Carfilzomib Maintenance or Control (AGMT MM 02 Study. Blood, 136(Supplement 1), S.29-30.

      • Petzer, A.L., Sperr, W.R., Buxhofer-Ausch, V., Sliwa, T., Schmidt, S., Greil, R., Wölfler, A., Pichler, P., Dormann, C., Burgstaller, S., Tinchon, C., Lang, A., Goebel, F., Uthman, S., Muenchmeier, N. & Valent, P., 2020. A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study. Wiener klinische Wochenschrift.

      • Petzl, A., Derndorfer, M., Kollias, G., Moroka, K., Aichinger, J., Purerfellner, H. & Martinek, M., 2020. Cerebral thromboembolic risk in atrial fibrillation ablation: a direct comparison of vitamin K antagonists versus non-vitamin K-dependent oral anticoagulants. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.

      • Pfisterer, N., Schmidbauer, C., Riedl, F., Maieron, A., Stadlbauer, V., Hennlich, B., Schwarzer, R., Puespoek, A., Bucsics, T., Effenberger, M., Bota, S., Gschwantler, M., Peck-Radosavljevic, M., Mandorfer, M., Madl, C., Trauner, M. & Reiberger, T., 2020. Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria. Wiener klinische Wochenschrift.

      • Podar, K., Shah, J., Chari, A., Richardson, P.G. & Jagannath, S., 2020. Selinexor for the treatment of multiple myeloma. Expert opinion on pharmacotherapy, S.1-10.

      • Poelzl, G., Fetz, B., Altenberger, J., Fritsch, M., Auer, J., Stachl, E., Böhmer, A., Frauendorfer, H., Ebner, C., Geyrhofer, F., Potz, S., Prim, A., Alber, H., de Grandis, R., Drack, C., Hulsmann, M., Working, G.Heart Fail, Cardiological, Athe Workin & for, C.Care Perso, 2020. Heart failure disease management programs in Austria 2019 : A systematic survey of the Heart Failure Working Group and the Working Group for Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology. Wiener klinische Wochenschrift.

      • Prager, G.W., Oehler, L., Gerger, A., Mlineritsch, B., Andel, J., Petzer, A., Wilthoner, K., Sliwa, T., Pichler, P., Winder, T., Heibl, S., Gruenberger, B., Laengle, F., Hubmann, E., Korger, M., Pecherstorfer, M., Djanani, A., Neumann, H.-J., Philipp-Abbrederis, K., Woll, E., Trondl, R., Arnold-Schrauf, C. & Eisterer, W., 2020. Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study. European journal of cancer, 143, S.101-112.

      • Razpotnik, M., Bota, S., Kutilek, M., Essler, G., Weber-Eibel, J., Maieron, A. & Peck-Radosavljevic, M., 2020. The bleeding risk after endoscopic ultrasound-guided puncture of pancreatic masses. Scandinavian journal of gastroenterology, S.1-6.

      • Reich, B., Benzer, W., Harpf, H., Hofmann, P., Mayr, K., Ocenasek, H., Podolsky, A., Pokan, R., Porodko, M., Puelacher, C., Sareban, M., Traninger, H., Ziegelmeyer, W. & Niebauer, J., 2020. Efficacy of extended, comprehensive outpatient cardiac rehabilitation on cardiovascular risk factors: A nationwide registry. European journal of preventive cardiology.

      • Riedl, J.Michael, Posch, F., Prager, G., Eisterer, W., Oehler, L., Sliwa, T., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Greil, R., Neumann, H.-J., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., Gruenberger, B., Laengle, F., Woll, E. & Gerger, A., 2020. The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study. Therapeutic advances in medical oncology, 12, S.1758835919900872.

      • Schukro, C., Santer, D., Prenner, G., Stuhlinger, M., Martinek, M., Teubl, A., Moertl, D., Schwarz, S., Nürnberg, M., Fiedler, L., Hatala, R. & Khazen, C., 2020. State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy. Clinical cardiology.

      • Smiljkovic, D., Kiss, R., Lupinek, C., Hoermann, G., Greiner, G., Witzeneder, N., Krajnik, G., Trautinger, F., Vrtala, S., Mittermann, I., Kundi, M., Jilma, B., Valenta, R., Sperr, W.R. & Valent, P., 2020. Microarray-based Detection of Allergen-Reactive IgE in Patients with Mastocytosis. The journal of allergy and clinical immunology. In practice.

      • Tobudic, S., Prager, I., Kussmann, M., Obermuller, M., Ursli, M., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W. & Reznicek, G., 2020. Compatibility of aztreonam in four commercial peritoneal dialysis fluids. Scientific reports, 10(1), S.1788.

      • Tripolt, N.J., Kolesnik, E., Pferschy, P.N., Verheyen, N., Ablasser, K., Sailer, S., Alber, H., Berger, R., Kaulfersch, C., Leitner, K., Lichtenauer, M., Mader, A., Moertl, D., Oulhaj, A., Reiter, C., Rieder, T., Saely, C.H., Siller-Matula, J., Weidinger, F., Zechner, P.M., von Lewinski, D., Sourij, H. & group, Estudy, 2020. Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial. American heart journal, 221, S.39-47.

      • Wagner, G., Stollenwerk, H.Karolina, Klerings, I., Pecherstorfer, M., Gartlehner, G. & Singer, J., 2020. Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review. OncoImmunology, 9(1), S.1774314.

      • Winter, M.-P., Bartko, P., Hofer, F., Zbiral, M., Burger, A., Ghanim, B., Kastner, J., Lang, I.M., Mascherbauer, J., Hengstenberg, C. & Goliasch, G., 2020. Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies. Scientific reports, 10(1), S.15568.

      • Zemrak, F., Raisi-Estabragh, Z., Khanji, M.Y., Mohiddin, S.A., Bruder, O., Wagner, A., Lombardi, M., Schwitter, J., van Rossum, A.C., Pilz, G., Nothnagel, D., Steen, H., Nagel, E., Prasad, S.K., Deluigi, C.C., Dill, T., Frank, H., Schneider, S., Mahrholdt, H. & Petersen, S.E., 2020. Left Ventricular Hypertrabeculation Is Not Associated With Cardiovascular Morbity or Mortality: Insights From the Eurocmr Registry. Frontiers in cardiovascular medicine, 7, S.158.

      • Zweiker, D., Sieghartsleitner, R., Fiedler, L., Toth, G.G., Luha, O., Stix, G., Gabriel, H., Vock, P., Lileg, B., Strouhal, A., Delle-Karth, G., Pfeffer, M., Aichinger, J., Tkalec, W., Steinwender, C., Sihorsch, K., Binder, R.K., Rammer, M., Barbieri, F., Mueller, S., Verheyen, N., Ablasser, K., Zirlik, A. & Scherr, D., 2020. Indications and Outcome in Patients Undergoing Left Atrial Appendage Closure-The Austrian LAAC Registry. Journal of clinical medicine, 9(10).

      • Zwickl, H., Hackner, K., Köfeler, H., Krzizek, E.-C., Muqaku, B., Pils, D., Scharnagl, H., Solheim, T.S., Zwickl-Traxler, E. & Pecherstorfer, M., 2020. Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia. Frontiers in Oncology, 10(1262).

    • Buchkapitel

      • Giese, R. & Hackner, K., 2020. Canine Olfaction. In J. Beauchamp, Davis, C., & Pleil, J. (Hrsg.): Breathborne Biomarkers and the Human Volatilome. Elsevier.

    • Konferenzbeitrag

      • Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E.F., Sattler, M., Pecherstorfer, M. & Podar, K., 2020. Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy. In Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020: Abstracts. 9.-11.10.2020. Online.

      • Ludwig, H., Melchardt, T., Andel, J., Gunsilius, E., Sormann, S., Hinke, A., Hartmann, B.L., Podar, K., Willenbacher, W., Egle, A., Petzer, A., Zojer, N., Woll, E., Ruckser, R., Bozic, B., Schmitt, C.A., Machherndl-Spandl, S., Krauth, M.-T., Schreder, M., Agis, H., Tinchon, C., Fillitz, M. & Greil, R., 2020. Quality of Life in Newly Diagnosed Patients with Multiple Myeloma Randomized to Either Krd or Ktd Induction Therapy Followed By Carfilzomib Maintenance or Control (AGMT MM 02 trial). In Blood 136 (Suppl. 1). S. 27-29.

      • Ludwig, H., Sormann, S., Zojer, N., Andel, J., Hartmann, B.L., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Woll, E., Ruckser, R., Bozic, B., Krauth, M.-T., Petzer, A., Schmitt, C.A., Machherndl-Spandl, S., Agis, H., Fillitz, M., Paiva, B. & Greil, R., 2020. Poster: Carfilzomib in combination with either Rd or Td overcomes the negative impact of HR cytogenetics in NDMM. Interim efficacy analysis of combined data of KRd vs. KTd followed by K maintenance or control. In 25th Congress of the European Hematology Association (EHA). COVID-19 Online.

      • Sehlke, R., Taubert, C., Alt, I., Rohrer, F., Fuchs, E., Vilagos, B., Krall, N., Christoph, M., Schumacher, M., Maurer, D., Hackner, K., Lafleur, J., Hefler, L., Fureder, T. & Vladimer, G.Ian, 2020. Abstract 5233: Towards patient-centric drug discovery: Analyzing drug action in malignant pleural effusions and ascites using high content imaging and deep learning. In AACR Annual Meeting 2020. April 27-28, 2020 and June 22-24. Philadelphia, PA, S. 5233-5233.

    • Andere wissenschaftliche Beiträge

      • Podar, K., 2020. Multiples Myelom 2020 – was für Patienten erreicht wurde. krebs:hilfe!, (5), S.30-33.

      • Podar, K., 2020. Stellenwert der autologen Stammzelltransplantation beim multiplen Myelom. JATROS Hämatologie & Onkologie, (2), S.6-9.

  3. 2019

    • Zeitschriftenartikel

      • Bauer, W.Rudolf, Lau, D.H., Wollmann, C.Georg, McGavigan, A., Mansourati, J., Reiter, T., Fromer, S., Ladd, M.E. & Quick, H.H., 2019. Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla. Scientific reports, 9(1), S.18243.

      • Berger, R., Hulsmann, M., Moertl, D. & Polzl, G., 2019. Curriculum heart failure : Task force curriculum heart failure of the working group on heart failure of the Austrian Cardiological Society. Wiener klinische Wochenschrift, 131, S.299-312.

      • Chari, A., Vogl, D.T., Gavriatopoulou, M., Nooka, A.K., Yee, A.J., Huff, C.A., Moreau, P., Dingli, D., Cole, C., Lonial, S., Dimopoulos, M., A. Stewart, K., Richter, J., Vij, R., Tuchman, S., Raab, M.S., Weisel, K.C., Delforge, M., Cornell, R.F., Kaminetzky, D., Hoffman, J.E., Costa, L.J., Parker, T.L., Levy, M., Schreder, M., Meuleman, N., Frenzel, L., Mohty, M., Choquet, S., Schiller, G., Comenzo, R.L., Engelhardt, M., Illmer, T., Vlummens, P., Doyen, C., Facon, T., Karlin, L., Perrot, A., Podar, K., Kauffman, M.G., Shacham, S., Li, L., Tang, S., Picklesimer, C., Saint-Martin, J.-R., Crochiere, M., Chang, H., Parekh, S., Landesman, Y., Shah, J., Richardson, P.G. & Jagannath, S., 2019. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. The New England journal of medicine, 381, S.727-738.

      • Eder, M., Strassl, R., Beinhardt, S., Stattermayer, A.Friedrich, Kozbial, K., Lagler, H., Holzmann, H., Trauner, M. & Hofer, H., 2019. High seroprevalence of anti-Hepatitis E antibodies in Austrian patients with autoimmune hepatitis. Liver International, 39(4), S.640-645.

      • Egle, A., Melchardt, T., Obrtlikova, P., Smolej, L., Kozak, T., Steurer, M., Andel, J., Burgstaller, S., Mikuskova, E., Gercheva, L., Nosslinger, T., Papajik, T., Ladicka, M., Girschikofsky, M., Hrubisko, M., Jager, U., Voskova, D., Pecherstorfer, M., Kralikova, E., Burcoveanu, C., Spasov, E., Petzer, A., Mihaylov, G., Raynov, J., Oexle, H., Zabernigg, A., Flochova, E., Palasthy, S., Stehlikova, O., Doubek, M., Altenhofer, P., Weiss, L., Magnes, T., Pleyer, L., Klingler, A., Mayer, J. & Greil, R., 2019. Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial. Cancer medicine, 8, S.1401-1405.

      • Flamm, S., K. Reddy, R., Zadeikis, N., Hassanein, T., Bacon, B.R., Maieron, A., Zeuzem, S., Bourliere, M., Calleja, J.L., Kosloski, M.P., Oberoi, R.K., Lin, C.-W., Yu, Y., Lovell, S., Semizarov, D. & Mensa, F.J., 2019. Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17, S.527-535 e6.

      • Grochenig, H.Peter, Waldhor, T., Haas, T., Wenzl, H., Steiner, P., Koch, R., Feichtenschlager, T., Eckhardt, G., Mayer, A., Kirchgatterer, A., Ludwiczek, O., Platzer, R., Papay, P., Gartner, J., Fuchssteiner, H., Miehsler, W., Peters, P.-G., Reicht, G., Kutschera, M., Dejaco, C., Vogelsang, H., Novacek, G. & Austrian, I.B.D.Stud, 2019. Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease. European journal of gastroenterology & hepatology, 31(10), S.1211-1219.

      • Gschwantler, M., Bamberger, T., Graziadei, I., Maieron, A., Katalinic, N. & Stauber, R., 2019. Burden of disease in patients with chronic hepatitis C in the Austrian REAL study. Wiener klinische Wochenschrift, 131(1-2), S.8-16.

      • Hackner, K., Errhalt, P. & Handzhiev, S., 2019. Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion. Therapeutic advances in medical oncology, 11, S.1758835919850341.

      • Hammer, A., Moertl, D., Schlager, O., Matschuck, M., Seidinger, D., Koppensteiner, R. & Steiner, S., 2019. Effects of n-3 PUFA on endothelial function in patients with peripheral arterial disease: a randomised, placebo-controlled, double-blind trial. The British journal of nutrition, 122(6), S.698-706.

      • Kussmann, M., Ferth, A., Obermuller, M., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W. & Reznicek, G., 2019. Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions. Scientific reports, 9, S.6512.

      • Li, S., Vallet, S., Sacco, A., Roccaro, A., Lentzsch, S. & Podar, K., 2019. Targeting transcription factors in multiple myeloma: evolving therapeutic strategies. Expert opinion on investigational drugs, 28, S.445-462.

      • Lind, J., Czernilofsky, F., Vallet, S. & Podar, K., 2019. Emerging protein kinase inhibitors for the treatment of multiple myeloma. Expert opinion on emerging drugs, 24, S.133-152.

      • Monino-Romero, S., Lexmond, W.S., Singer, J., Bannert, C., Amoah, A.S., Yazdanbakhsh, M., Boakye, D.A., Jensen-Jarolim, E., Fiebiger, E. & Szepfalusi, Z., 2019. Soluble FcvarepsilonRI: A biomarker for IgE-mediated diseases. Allergy, 74, S.1381-1384.

      • Odeneg, T., Ebner, C., Moertl, D., Keller, H., Dirninger, A., Stix, G., Foger, B., Grimm, G., Steinwender, C., Gebetsberger, F., Stuhlinger, M., Mastnak, B., Haider, C., Manninger, M. & Scherr, D., 2019. Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 18, S.75-83.

      • Pfisterer, N., Riedl, F., Pachofszky, T., Gschwantler, M., Konig, K., Schuster, B., Mandorfer, M., Gessl, I., Illiasch, C., Fuchs, E.-M., Unger, L., Dolak, W., Maieron, A., Kramer, L., Madl, C., Trauner, M. & Reiberger, T., 2019. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study. Liver International, 39(2), S.290-298.

      • Riedl, J., Posch, F., Prager, G., Eisterer, W., Ohler, L., Thamer, S., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Greil, R., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., Gruenberger, B., Langle, F., Woll, E. & Gerger, A., 2019. The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study. Annals of oncology: official journal of the European Society for Medical Oncology, 30 Suppl 4, S.iv78.

      • Schwarzer, R., Reiberger, T., Mandorfer, M., Kivaranovic, D., Hametner, S., Hametner, S., Paternostro, R., Scheiner, B., Schneeweiss-Friedl, J., Trauner, M., Schoefl, R. & Maieron, A., 2019. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. Journal of gastroenterology.

      • Senoner, T., Barbieri, F., Semmler, G., Adukauskaite, A., Rubatscher, A., Schgor, W., Stuhlinger, M., Bauer, A., Pfeifer, B.Erich, Fiedler, L., Roithinger, F.Xaver, Hintringer, F., Suessenbacher, A., Wollmann, C.Georg & Dichtl, W., 2019. Long-term performance of an atrial lead capable of accelerometer based detection of cardiac contractility in patients receiving cardiac resynchronisation therapy. PloS one, 14, S.e0222269.

      • Singer, J., Achatz-Straussberger, G., Bentley-Lukschal, A., Fazekas-Singer, J., Achatz, G., Karagiannis, S.N. & Jensen-Jarolim, E., 2019. AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice. The World Allergy Organization journal, 12, S.100044.

      • Vallet, S., Fan, F., Malvestiti, S., Pecherstorfer, M., Sattler, M., Schneeweiss, A., Schulze-Bergkamen, H., Opferman, J.T., Cardone, M.H., Jager, D. & Podar, K., 2019. Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer. Breast cancer research and treatment, 173, S.585-596.

      • Wagner, G., Haumer, M., Poelzl, G., Wiedemann, D., Kliegel, A., Ullrich, R., Gartlehner, G., Zuckermann, A., Muller, L., Mayr, H. & Moertl, D., 2019. A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation. BMC cardiovascular disorders, 19(1), S.302.

      • Wagner, G., Steiner, S., Gartlehner, G., Arfsten, H., Wildner, B., Mayr, H. & Moertl, D., 2019. Comparison of transcatheter aortic valve implantation with other approaches to treat aortic valve stenosis: a systematic review and meta-analysis. Systematic reviews, 8(1), S.44.

      • Zbinden, R., Wollmann, C.Georg, Brachmann, J., Michaelsen, J., Steinwender, C., Kovoor, P., Kelle, S., McGavigan, A.D., Ching, C.Keong, Figtree, G.A., Schmidt, J., Timmel, T. & Lotz, J., 2019. Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(11), S.1678-1685.

      • Zwickl, H., Zwickl-Traxler, E. & Pecherstorfer, M., 2019. Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives. Frontiers in oncology, 9, S.1409.

    • Konferenzbeitrag

      • Fan, F., Malvestiti, S., Shen, Y., Morelli, E., Mishima, Y., Seckinger, A., Hose, D., Bakiri, L., Vallet, S., Sattler, M., Roccaro, A.M., Goldschmidt, H., Percherstorfer, M., Sun, C., Hu, Y., Wagner, E.F., Tassone, P., Ghobrial, I.M., Jaeger, D. & Podar, K., 2019. Multiple Myeloma Pathogenesis: The Role of Junb in Bone Marrow Angiogenesis. In American Society of Hematology, 61th Annual Meeting, scientific session. Orlando, FL.

      • Grech, C., Hackner, K., Buder, A., Strieder, M., Hochmair, M.J., Filipits, M. & Errhalt, P., 2019. Analysis of circulating tumor DNA in paired plasma and sputum samples of EGFR-mutated NSCLC patients. In European society for medical oncology. Barcelona.

      • Hackner, K., Javaheri, S., Gerges, C., Kneussl, M.P., Errhalt, P., Gerges, M., Maurer, M. & Lang, I.M., 2019. Sleep-Disordered Breathing and Hypoxemia in Treatment-Naïve Patients with Chronic Thromboembolic Pulmonary Hypertension. In American Thoracic Society. Dallas, S. A1994.

      • Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E.F., Sattler, M., Pecherstorfer, M. & Podar, K., 2019. Poster: Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy. In 17th International Myeloma Workshop. Boston.

      • Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Sattler, M., Bakiri, L., Wagner, E.F., Percherstorfer, M. & Podar, K., 2019. Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs for Multiple Myelioma Therapy. In American Society of Hematology, 61th Annual Meeting, scientific session. Orlando, FL.

      • Ludwig, H., Sormann, S., Zojer, N., Andel, J., Hartmann, B.L., Tinchon, C., Gunsilius, E., Podar, K., Egle, A., Willenbacher, W., Woll, E., Ruckser, R., Bozic, B., Krauth, M.-T., Petzer, A., Schmitt, C.A., Machherndl-Spandl, S., Agis, H., Paiva, B. & Greil, R., 2019. Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Ef. In American Society of Hematology, 61th Annual Meeting, scientific session. Orlando, FL.

      • Podar, K., 2019. Multiples Myelom II. In DGHO, OeGHO, SGMO & SGH 2019 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie). Berlin.

      • Podar, K., 2019. Präsentation: Klinisch relevante Arzneimittelinteraktionen im Multiplen Myelom. In Hämatologie im Wandel der Zeit . 28.-29.06.2019. Wien.

      • Podar, K., 2019. Präsentation: Stellenwert der Autologen Stammzelltransplantation beim Multiplen Myelom. In 9. Niederösterreichischer Onkologietag. Krems.

      • Podar, K., 2019. Presentation: Targeting transcription factors for cancer therapy: evolving therapeutic strategies . In 9. Niederösterreichischer Onkologietag. Krems.

      • Stättermayer, M.-S., Riedl, F., Bernhofer, S., Stättermayer, A., Mayer, A. & Maieron, A., 2019. Poster: Prospective evaluation for gastrointestinal bleedings at the University Hospital St. Pölten – one year of follow-up. In ÖGGH-Jahrestagung.

      • Stättermayer, M.-S., Riedl, F., Bernhofer, S., Stättermayer, A., Mayer, A. & Maieron, A., 2019. Poster: Prospective evaluation of blood transfusion management in patients with gastrointestinal bleedings at the University Hospital St. Pölten. In ÖGGH-Jahrestagung.

  4. 2018

    • Zeitschriftenartikel

      • Balber, T., Singer, J., Berroteran-Infante, N., Dumanic, M., Fetty, L., Fazekas-Singer, J., Vraka, C., Nics, L., Bergmann, M., Pallitsch, K., Spreitzer, H., Wadsak, W., Hacker, M., Jensen-Jarolim, E., Viernstein, H. & Mitterhauser, M., 2018. Preclinical In Vitro and In Vivo Evaluation of [(18)F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer. Contrast Media & Molecular Imaging, 2018, S.1269830.

      • Beinhardt, S., Al-Zoairy, R., Kozbial, K., Stattermayer, A.F., Maieron, A., Stauber, R., Strasser, M., Zoller, H., Graziadei, I., Rasoul-Rockenschaub, S., Trauner, M., Ferenci, P. & Hofer, H., 2018. Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation. Liver International, 38, S.1188-1197.

      • Breitkreutz, I., Podar, K., Figueroa-Vazquez, V., Wilhelm, S., Hayden, P.J., Anderson, K.C. & Raab, M.S., 2018. The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma. Annals of Hematology, 97, S.839-849.

      • Buder, A., Hochmair, M.J., Schwab, S., Bundalo, T., Schenk, P., Errhalt, P., Mikes, R.E., Absenger, G., Patocka, K., Baumgartner, B., Setinek, U., Burghuber, O.C., Prosch, H., Pirker, R. & Filipits, M., 2018. Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC. Journal of Thoracic Oncology, 13, S.821-830.

      • Fazekas-Singer, J., Singer, J., Ilieva, K.M., Matz, M., Herrmann, I., Spillner, E., Karagiannis, S.N. & Jensen-Jarolim, E., 2018. AllergoOncology: Generating a canine anticancer IgE against the epidermal growth factor receptor. Journal of Allergy and Clinical Immunology, 142, S.973-976.e11.

      • Hintermair, S., Zwickl-Traxler, E., Pecherstorfer, M. & Singer, J., 2018. Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015. Oncotarget, 9, S.8450-8462.

      • Kozbial, K., Moser, S., Al-Zoairy, R., Schwarzer, R., Datz, C., Stauber, R., Laferl, H., Strasser, M., Beinhardt, S., Stattermayer, A.F., Gschwantler, M., Zoller, H., Maieron, A., Graziadei, I., Trauner, M., Steindl-Munda, P., Hofer, H. & Ferenci, P., 2018. Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment. Liver International, 38, S.1028-1035.

      • Krammel, M., Schnaubelt, S., Weidenauer, D., Winnisch, M., Steininger, M., Eichelter, J., Hamp, T., van Tulder, R.Henricus & Sulzgruber, P., 2018. Gender and age-specific aspects of awareness and knowledge in basic life support. PLoS One, 13, S.e0198918.

      • Kreye, G., Masel, E.K., Hackner, K., Stich, B. & Nauck, F., 2018. Methadone as anticancer treatment: hype, hope, or hazard? : A series of case reports and a short review of the current literature and recommendations of the societies. Wiener Medizinische Wochenschrift, 168, S.159-167.

      • Kussmann, M., Hauer, S., Pichler, P., Reznicek, G., Burgmann, H., Poeppl, W., Zeitlinger, M. & Wiesholzer, M., 2018. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases, 37, S.1091-1098.

      • Masel, E.K. & Kreye, G., 2018. Demystification of palliative care: what palliative care teams don't want you to think about them. memo - Magazine of European Medical Oncology, 11, S.193-195.

      • Miehsler, W., Dejaco, C., Grochenig, H.-P., Fuchssteiner, H., Hogenauer, C., Kazemi-Shirazi, L., Maier, H., Mayer, A., Moschen, A., Reinisch, W., Petritsch, W., Platzer, R., Steiner, P., Tilg, H., Vogelsang, H., Wenzl, H. & Novacek, G., 2018. Zweiter österreichischer Konsensus zur sicheren Anwendung von anti-TNF-alpha-Antikörpern bei chronisch-entzündlichen Darmerkrankungen. Zeitschrift fur Gastroenterologie, 56(3), S.275-302.

      • Neuhold, U., Rohla, M., Glaser, F. & Mihalcz, A., 2018. Eine seltene Rhythmusstörung. Journal für Kardiologie, 25, S.30-33.

      • Pirich, T., Zwickl-Traxler, E., Pecherstorfer, M. & Singer, J., 2018. Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study. Oncotarget, 9, S.29944-29956.

      • Podar, K., 2018. Choosing an appropriate salvage therapy for a patient with multiple myeloma. Expert Opinion on Pharmacotherapy, 19, S.1511-1516.

      • Poeppl, W., Rainer-Harbach, E., Kussmann, M., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H. & Reznicek, G., 2018. Compatibility of linezolid with commercial peritoneal dialysis solutions. American Journal of Health-System Pharmacy, 75, S.1467-1477.

      • Rohla, M., Tscharre, M., Huber, K. & Weiss, T.W., 2018. Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial. Wiener klinische Wochenschrift, 130, S.698-706.

      • Sponder, M., Khazen, C., Dichtl, W., Fiedler, L., Moertl, D., Teubl, A., Steinwender, C., Martinek, M., Nurnberg, M., Dalos, D., Kastner, J. & Schukro, C., 2018. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry. European Journal of Internal Medicine, 48, S.64-68.

      • Steger, G.G., Dominguez, A., Dobrovolskaya, N., Giotta, F., Tubiana-Mathieu, N., Pecherstorfer, M., Ardizzoia, A., Blasinska-Morawiec, M., Espinosa, E. & Villanova, G., 2018. Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study. Clinical breast cancer, 18(1), S.e41-e47.

      • Strieder, M., Pecherstorfer, M. & Kreye, G., 2018. Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature. Wiener Medizinische Wochenschrift, 168, S.333-343.

      • Vallet, S., Filzmoser, J.M., Pecherstorfer, M. & Podar, K., 2018. Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies. Pharmaceutics, 10, S.202.

      • Vallet, S., Hoyle, N.R., Kyle, R.A., Podar, K. & Pecherstorfer, M., 2018. A role for bone turnover markers beta-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma. Leukemia & Lymphoma, 59, S.2431-2438.

      • Vychytil, A., Herzog, R., Probst, P., Ribitsch, W., Lhotta, K., Machold-Fabrizii, V., Wiesholzer, M., Kaufmann, M., Salmhofer, H., Windpessl, M., Rosenkranz, A.R., Oberbauer, R., Konig, F., Kratochwill, K. & Aufricht, C., 2018. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health. Kidney International.

      • Wurm, R., Schrutka, L., Hammer, A., Moertl, D., Berger, R., Pavo, N., Lang, I.M., Goliasch, G., Huelsmann, M. & Distelmaier, K., 2018. Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure. European Journal of Clinical Investigation, 48, S.e12998.

    • Konferenzbeitrag

      • Malvestiti, S., Fan, F., Bashari, H.M., Morelli, E., Seckinger, A., Hose, D., Goldschmidt, H., Zoernig, I., Bakiri, L., Sattler, M., Vallet, S., Pecherstorfer, M., Wagner, E.F., Tassone, P., Jaeger, D. & Podar, K., 2018. Poster: Multiple myeloma pathogenesis: The role of JunB in bone marrow angiogenesis. In 23rd Congress of the European Hematology Association (EHA). Stockholm, Sweden.

      • Podar, K., 2018. Presentation: Transcription factors in multiple myeloma: new potential targets. In 4th Multiple Myeloma and related malignancies. Bari, Italy.

      • Podar, K., 2018. Therapiefortschritte – Hämato-Onkologie im Jahr 2018: Multiples Myelom. In 8. Niederösterreichischer Onkologietag. Krems.

    • Andere wissenschaftliche Beiträge

      • Podar, K., 2018. Immunmodulierende Medikamente bleiben essenzielle Basis der Therapie. JATROS Hämatologie & Onkologie, (5), S.41.

      • Podar, K., 2018. Teamwork gegen Krebs. Gesund leben in Niederösterreich, (6), S.30-32.

  5. 2017

    • Zeitschriftenartikel

      • Auer, J., Verbrugge, F.H. & Lamm, G., 2017. What do small serum creatinine changes tell us about outcomes after acute myocardial infarction?. European Heart Journal: Acute Cardiovascular Care, S.2048872617728721.

      • Bhanot, H., Weisberg, E.L., Reddy, M.M., Nonami, A., Neuberg, D., Stone, R.M., Podar, K., Salgia, R., Griffin, J.D. & Sattler, M., 2017. Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming. Oncotarget, 8, S.67639-67650.

      • Fan, F., Bashari, M.H., Morelli, E., Tonon, G., Malvestiti, S., Vallet, S., Jarahian, M., Seckinger, A., Hose, D., Bakiri, L., Sun, C., Hu, Y., Ball, C.R., Glimm, H., Sattler, M., Goldschmidt, H., Wagner, E.F., Tassone, P., Jaeger, D. & Podar, K., 2017. The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment. Leukemia, 31, S.1570-1581.

      • Fazekas, J., Grunt, T.W., Jensen-Jarolim, E. & Singer, J., 2017. Long term storage in liquid nitrogen leads to only minor phenotypic and gene expression changes in the mammary carcinoma model cell line BT474. Oncotarget, 8, S.35076-35087.

      • Fazekas-Singer, J., Berroteran-Infante, N., Rami-Mark, C., Dumanic, M., Matz, M., Willmann, M., Andreae, F., Singer, J., Wadsak, W., Mitterhauser, M. & Jensen-Jarolim, E., 2017. Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials. Oncotarget, 8, S.83128-83141.

      • Giustino, G., Redfors, B., Brener, S.J., Kirtane, A.J., Genereux, P., Maehara, A., Dudek, D., Neunteufl, T., Metzger, D.C., Crowley, A., Mehran, R., Gibson, C.M. & Stone, G.W., 2017. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. European Heart Journal: Acute Cardiovascular Care, S.2048872617719649.

      • Hackner, K. & Pleil, J., 2017. Canine olfaction as an alternative to analytical instruments for disease diagnosis: understanding 'dog personality' to achieve reproducible results. Journal of Breath Research, 11, S.012001.

      • Hackner, K., Errhalt, P. & Doll, T., 2017. Reply to Comment on 'Canine scent detection for the diagnosis of lung cancer in a screening-like situation'. Journal of Breath Research, 11, S.038002.

      • Hackner, K., Riegler, W., Handzhiev, S., Bauer, R., Veres, J., Speiser, M., Meisinger, K. & Errhalt, P., 2017. Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection. BMC Pulmonary Medicine, 17, S.156.

      • Koller, L., Richter, B., Winter, M.P., Sulzgruber, P., Potolidis, C., Liebhart, F., Moertl, D., Berger, R., Goliasch, G., Lang, I., Wojta, J., Hulsmann, M. & Niessner, A., 2017. Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure. Journal of Clinical Lipidology, 11, S.178-184.

      • Kussmann, M., Baumann, A., Hauer, S., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W. & Reznicek, G., 2017. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. European Journal of Clinical Microbiology & Infectious Diseases, 36, S.2237-2242.

      • Lebherz-Eichinger, D., Tudor, B., Ankersmit, H.J., Reiter, T., Haas, M., Einwallner, E., Roth-Walter, F., Krenn, C.G. & Roth, G.A., 2017. Increased trefoil factor 2 levels in patients with chronic kidney disease. PLoS One, 12, S.e0174551.

      • Marek, S., Gamper, G., Reining, G., Bergmann, P., Mayr, H. & Kliegel, A., 2017. ECMO and cytokine removal for bridging to surgery in a patient with ischemic ventricular septal defect - a case report. The International Journal of Artificial Organs, 40, S.526-529.

      • Moertl, D., Altenberger, J., Bauer, N., Berent, R., Berger, R., Böhmer, A., Ebner, C., Fritsch, M., Geyrhofer, F., Huelsmann, M., Poelzl, G. & Stefenelli, T., 2017. Disease management programs in chronic heart failure : Position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology. Wiener klinische Wochenschrift, 129, S.869-878.

      • Podar, K. & Jager, D., 2017. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma. Current Cancer Drug Targets, 17, S.782-805.

      • Podar, K. & Pecherstorfer, M., 2017. Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma. Expert Opinion on Pharmacotherapy, 18, S.1061-1079.

      • Reiberger, T., Puspok, A., Schoder, M., Baumann-Durchschein, F., Bucsics, T., Datz, C., Dolak, W., Ferlitsch, A., Finkenstedt, A., Graziadei, I., Hametner, S., Karnel, F., Krones, E., Maieron, A., Mandorfer, M., Peck-Radosavljevic, M., Rainer, F., Schwabl, P., Stadlbauer, V., Stauber, R., Tilg, H., Trauner, M., Zoller, H., Schofl, R. & Fickert, P., 2017. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wiener klinische Wochenschrift, 129, S.135-158.

      • Sandhofer, M.J., Robak, O., Frank, H. & Kulnig, J., 2017. Vaccine hesitancy in Austria : A cross-sectional survey. Wiener klinische Wochenschrift, 129, S.59-64.

      • Vallet, S., Pecherstorfer, M. & Podar, K., 2017. Adoptive cell therapy in multiple Myeloma. Expert Opinion on Biological Therapy, 17, S.1511-1522.

      • Wiesholzer, M., Winter, A., Kussmann, M., Zeitlinger, M., Pichler, P., Burgmann, H., Reznicek, G. & Poeppl, W., 2017. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions. Peritoneal Dialysis International, 37, S.51-55.

      • Worel, N., Fritsch, G., Agis, H., Bohm, A., Engelich, G., Leitner, G.C., Geissler, K., Gleixner, K., Kalhs, P., Buxhofer-Ausch, V., Keil, F., Kopetzky, G., Mayr, V., Rabitsch, W., Reisner, R., Rosskopf, K., Ruckser, R., Zoghlami, C., Zojer, N. & Greinix, H.T., 2017. Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure. Journal of Clinical Apheresis, 32, S.224-234.

      • Zangrando, M.Maurizio, Böhmer, A. & Glaser, F., 2017. Kardiale Sarkoidose mit Normalisierung einer schwer reduzierten links- und rechtsventrikulären Pumpfunktion. Austrian Journal of Cardiology, 24, S.216-221.

  6. 2016

    • Zeitschriftenartikel

      • Bohn, B., Kerner, W., Seufert, J., Kempe, H.P., Jehle, P.M., Best, F., Fuchtenbusch, M., Knauerhase, A., Hofer, M., Rosenbauer, J. & Holl, R.W., 2016. Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: Analysis of real-life data from the DPV registry from Germany and Austria. Diabetes Research and Clinical Practice, 115, S.31-8.

      • Dalos, D., Gangl, C., Roth, C., Krenn, L., Scherzer, S., Vertesich, M., Lang, I., Maurer, G., Neunteufl, T., Berger, R. & Delle-Karth, G., 2016. Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent. BMC Cardiovascular Disorders, 16, S.104.

      • Geltner, C., Errhalt, P., Baumgartner, B., Ambrosch, G., Machan, B., Eckmayr, J., Klikovits, T., Hoda, M.Alireza, Popper, H. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 1: epidemiology, diagnosis, and staging. Wiener klinische Wochenschrift, 128, S.611-617.

      • Gennaro, G., Brener, S.J., Redfors, B., Kirtane, A.J., Genereux, P., Maehara, A., Neunteufl, T., Metzger, D.C., Mehran, R., Gibson, C.M. & Stone, G.W., 2016. Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial). American Journal of Cardiology, 118, S.1097-1104.

      • Gohl, O., Walker, D.J., Walterspacher, S., Langer, D., Spengler, C.M., Wanke, T., Petrovic, M., Zwick, R.Harun, Stieglitz, S., Glockl, R., Dellweg, D. & Kabitz, H.J., 2016. Atemmuskeltraining: State-of-the-Art. Pneumologie, 70(1), S.37-48.

      • Grave, M.S., Sterz, F., Nurnberger, A., Fykatas, S., Gatterbauer, M., Stattermayer, A.F., Zajicek, A., Malzer, R., Sebald, D. & van Tulder, R.Henricus, 2016. Safety and feasibility of the RhinoChill immediate transnasal evaporative cooling device during out-of-hospital cardiopulmonary resuscitation: A single-center, observational study. Medicine, 95, S.e4692.

      • Greil, R., Obrtlikova, P., Smolej, L., Kozak, T., Steurer, M., Andel, J., Burgstaller, S., Mikuskova, E., Gercheva, L., Nosslinger, T., Papajik, T., Ladicka, M., Girschikofsky, M., Hrubisko, M., Jager, U., Fridrik, M., Pecherstorfer, M., Kralikova, E., Burcoveanu, C., Spasov, E., Petzer, A., Mihaylov, G., Raynov, J., Oexle, H., Zabernigg, A., Flochova, E., Palasthy, S., Stehlikova, O., Doubek, M., Altenhofer, P., Pleyer, L., Melchardt, T., Klingler, A., Mayer, J. & Egle, A., 2016. Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial. The Lancet Haematology, 3, S.e317-29.

      • Hackner, K., Errhalt, P., Mueller, M.Rolf, Speiser, M., Marzluf, B.A., Schulheim, A., Schenk, P., Bilek, J. & Doll, T., 2016. Canine scent detection for the diagnosis of lung cancer in a screening-like situation. Journal of Breath Research, 10, S.046003.

      • Hoda, M.A., Klikovits, T., Arns, M., Dieckmann, K., Zochbauer-Muller, S., Geltner, C., Baumgartner, B., Errhalt, P., Machan, B., Pohl, W., Hutter, J., Eckmayr, J., Studnicka, M., Flicker, M., Cerkl, P. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG). Wiener klinische Wochenschrift, 128, S.618-26.

      • Kettenbach, J., Mittendorfer, M., Wimmer, I., Mader, M., Taubenschuss, E., Unfried, E. & Heinz, G., 2016. Transgastric biopsy of a submucosal gastric tumour. BJR Case Reports, 2, S.20160009.

      • Klikovits, T., Hoda, M.A., Dong, Y., Arns, M., Baumgartner, B., Errhalt, P., Geltner, C., Machan, B., Pohl, W., Hutter, J., Eckmayr, J., Studnicka, M., Flicker, M., Cerkl, P., Kirchbacher, K. & Klepetko, W., 2016. Management of malignant pleural mesothelioma – Part 3: Data from the Austrian Mesothelioma Interest Group (AMIG) database. Wiener klinische Wochenschrift, 128, S.627-34.

      • Kussmann, M., Schuster, L., Wrenger, S., Pichler, P., Reznicek, G., Burgmann, H., Poeppl, W., Zeitlinger, M. & Wiesholzer, M., 2016. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli. Peritoneal Dialysis International, 36, S.662-668.

      • Lammerich, A., Balcke, P., Bias, P., Mangold, S. & Wiesholzer, M., 2016. Cardiovascular Morbidity and Pure Red Cell Aplasia Associated With Epoetin Theta Therapy in Patients With Chronic Kidney Disease: A Prospective, Noninterventional, Multicenter Cohort Study. Clinical Therapeutics, 38, S.276-287 e4.

      • Moser, M., Wiedemann, D., Kitzwögerer, M. & Frank, H., 2016. Adenocarcinoma of the ampulla of Vater metastasising into the right ventricle. BMJ Case Reports, 2016.

      • Roth, C., Berger, R., Scherzer, S., Krenn, L., Gangl, C., Dalos, D., Delle-Karth, G. & Neunteufl, T., 2016. Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study. Heart and vessels, 31(8), S.1266-76.

      • Roth, C., Gangl, C., Dalos, D., Krenn, L., Scherzer, S., Gerken, A., Reinwein, M., Zhang, C., Hagmann, M., Wrba, T., Delle-Karth, G., Neunteufl, T., Maurer, G., Vock, P., Mayr, H., Frey, B. & Berger, R., 2016. Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy. PLoS One, 11, S.e0154025.

      • Schur, S., Weixler, D., Gabl, C., Kreye, G., Likar, R., Masel, E.K., Mayrhofer, M., Reiner, F., Schmidmayr, B., Kirchheiner, K. & Watzke, H.H., 2016. Sedation at the end of life - a nation-wide study in palliative care units in Austria. BMC Palliative Care, 15, S.50.

      • Wagner, G., Moertl, D., Eckhardt, A., Sagel, U., Wrba, F., Dam, K. & Willinger, B., 2016. Chronic Paracoccidioidomycosis with adrenal involvement mimicking tuberculosis - A case report from Austria. Medical Mycology Case Reports, 14, S.12-16.

      • Wiesholzer, M., Pichler, P., Reznicek, G., Wimmer, M., Kussmann, M., Balcke, P., Burgmann, H., Zeitlinger, M. & Poeppl, W., 2016. An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis. Antimicrobial Agents and Chemotherapy, 60, S.2790-7.

      • Zwickl, H., Zwickl-Traxler, E. & Pecherstorfer, M., 2016. A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone. Leukemia & Lymphoma, 57, S.2065-70.

  7. 2015

    • Zeitschriftenartikel

      • Duck, A., Pigram, L., Errhalt, P., Ahmed, D. & Chaudhuri, N., 2015. IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe. Advances in Therapy, 32, S.87-107.

      • Errhalt, P., 2015. Idiopathische Pulmonale Fibrose - ein Update. Journal für Pneumologie, 3, S.11-17.

      • Geltner, C. & Errhalt, P., 2015. Malignant pleural effusion: pathogenesis, diagnosis, and management. memo - Magazine of European Medical Oncology, 8, S.235-241.

      • Grabner, B., Schramek, D., Mueller, K.M., Moll, H.P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., Stiedl, P., Nivarthi, H., Bogner, E., Gruber, W., Mohr, T., Zwick, R.Harun, Kenner, L., Poli, V., Aberger, F., Stoiber-Sakaguchi, D., Egger, G., Esterbauer, H., Zuber, J., Moriggl, R., Eferl, R., Gyorffy, B., Penninger, J.M., Popper, H. & Casanova, E., 2015. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nature Communications, 6, S.6285.

      • Kussmann, M., Schuster, L., Zeitlinger, M., Pichler, P., Reznicek, G., Wiesholzer, M., Burgmann, H. & Poeppl, W., 2015. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis. European Journal of Clinical Microbiology & Infectious Diseases, 34, S.2257-63.

      • Lamprecht, B., Mikes, R., Aigner, K., Auer, W., Bolitschek, J., Errhalt, P., Fazekas, A., Flick, H., Funk, G.-C. & Haider, A., 2015. Abstracts Jahrestagung 2015 der Österreichischen Gesellschaft für Pneumologie. Wiener klinische Wochenschrift, 127, S.803-839.

      • Sandhofer, M.J., Salzer, H. & Kulnig, J., 2015. Foreign body aspiration - Sometimes a tough nut to crack. Respiratory Medicine Case Reports, 15, S.18-9.

      • Stadlbauer, A., Pichler, P., Karl, M., Brandner, S., Lerch, C., Renner, B. & Heinz, G., 2015. Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy. European journal of radiology, 84(6), S.1128-36.

      • van Tulder, R.Henricus, Laggner, R., Kienbacher, C., Schmid, B., Zajicek, A., Haidvogel, J., Sebald, D., Laggner, A.N., Herkner, H., Sterz, F. & Eisenburger, P., 2015. The capability of professional- and lay-rescuers to estimate the chest compression-depth target: a short, randomized experiment. Resuscitation, 89, S.137-41.

      • Wimmer, I., Minear, G., Brustbauer, R., Götzinger, P. & Dam, K., 2015. Pancreatic VIPoma visualized by 68Ga DOTA-NOC PET-CT. Nuklearmedizin, 54, S.N32-3.

      • Wollmann, C.Georg, Gradaus, R., Bocker, D., Fetsch, T., Hintringer, F., Hoh, G., Hatala, R., Podczeck-Schweighofer, A., Kreutzer, U., Kamaryt, P., Hauser, T., Kersten, J.F., Wegscheider, K. & Breithardt, G., 2015. Variations of heart rate variability parameters prior to the onset of ventricular tachyarrhythmia and sinus tachycardia in ICD patients. Results from the heart rate variability analysis with automated ICDs (HAWAI) registry. Physiological Measurement, 36, S.1047-61.

      • Wollmann, C.Georg, Steiner, E., Kleinjung, F. & Mayr, H., 2015. A detailed view on pacemaker lead parameters remotely transmitted after magnetic resonance. Pacing and Clinical Electrophysiology, 38, S.746-57.

      • Zwick, R.Harun & Lichtenschopf, A., 2015. Geschichte der pneumologischen Rehabilitation und der Status quo in Österreich. Pneumologie, 69(9), S.545-8.

  8. 2014

    • Zeitschriftenartikel

      • Erbel, R., Aboyans, V., Boileau, C., Bossone, E., Di Bartolomeo, R., Eggebrecht, H., Evangelista, A., Falk, V., Frank, H., Gaemperli, O., Grabenwoger, M., Haverich, A., Iung, B., Manolis, A.J., Meijboom, F., Nienaber, C.A., Roffi, M., Rousseau, H., Sechtem, U., Sirnes, P.A., von Allmen, R.S. & Vrints, C.J., 2014. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Polish Heart Journal, 72, S.1169-252.

      • Kopec, G., Moertl, D., Miszalski-Jamka, T., Waligora, M., Tyrka, A., Sarnecka, A. & Podolec, P., 2014. Left ventricular mass is preserved in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. Heart, Lung and Circulation, 23, S.454-61.

      • Oberndorfer, S., Ungersboeck, K., Moser, W., Riedlberger, U., Marhold, F., Heinz, G., Sedivy, R., Brustbauer, R., Kopetzky, G., Vyhnalik, M. & Balcke, P., 2014. Interdisziplinäre neuroonkologische Betreuung eines Patienten mit sekundärem Gliobalstom. Tumorboard, 3, S.13-16.

      • Poelzl, G., Altenberger, J., Pacher, R., Ebner, C.H., Wieser, M., Winter, A., Fruhwald, F., Dornaus, C., Ehmsen, U., Reiter, S., Steinacher, R., Huelsmann, M., Eder, V., Böhmer, A., Pilgersdorfer, L., Ablasser, K., Keroe, D., Groebner, H., Auer, J., Jakl, G., Hallas, A., Ess, M., Ulmer, H. & Heart, F.Austrian W., 2014. Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure. International Journal of Cardiology, 175, S.83-9.

      • Schilling, M., Sailer, A.S., Heinz, G. & Kutilek, M., 2014. Intrathorakale Perforation von Gallenwegsstents bei St. p. Lebertransplantation. Röfo, 186, S.887-8.

      • Teischinger, L., Plass, C., Mayr, H. & Frey, B., 2014. A wide QRS complex tachycardia: what is the mechanism?. Heart Rhythm, 11, S.1079-81.

      • Troughton, R.W., Frampton, C.M., La Rocca, H.P.Brunner, Pfisterer, M., Eurlings, L.W., Erntell, H., Persson, H., O'Connor, C.M., Moertl, D., Karlstrom, P., Dahlstrom, U., Gaggin, H.K., Januzzi, J.L., Berger, R., Richards, A.M., Pinto, Y.M. & Nicholls, M.G., 2014. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. European Heart Journal, 35, S.1559-67.

      • Uitz, E., Bahadori, B., McCarty, M.F. & Moghadasian, M.H., 2014. Practical strategies for modulating foam cell formation and behavior. World Journal of Clinical Cases, 2, S.497-506.

      • Wimmer, I., Hartmann, T., Brustbauer, R., Minear, G. & Dam, K., 2014. Selenium levels in patients with autoimmune thyroiditis and controls in lower Austria. Hormone and Metabolic Research, 46, S.707-9.

      • Wollmann, C.Georg, 2014. Reel syndrome in an ICD with DF4 connector. Herzschrittmachertherapie + Elektrophysiologie, 25, S.206-8.

      • Wollmann, C.Georg, Lawo, T., Kuhlkamp, V., Becker, R., Garutti, C., Jackson, T., Brown, M.L. & Mayr, H., 2014. Implantable defibrillators with enhanced detection algorithms: detection performance and safety results from the PainFree SST study. Pacing and Clinical Electrophysiology, 37, S.1198-209.

      • Zweiker, D., Maier, R., Lamm, G., Maurer, E., Heigert, M., Neunteufl, T., Zeindlhofer, E., Grund, M., Aichinger, J., Huber, K., Schneider, J., Pollak, J., Luha, O. & Zweiker, R., 2014. The Austrian transcatheter aortic valve implantation (TAVI) Registry--3 years' data. International Journal of Cardiology, 177, S.114-6.

Events

  1. 03 Dez

    International Water Asociation HRWM - Webinar Mini-Symposium

    03. Dezember 2021, 15:00 - 16:00
    Zoom Meeting, online
  2. 15 Dez

    KL Lunchtime Seminar: Towards Natural Killer Cell-Based Immune Therapy in Leukemia

    15. Dezember 2021, 12:00 - 13:00
    Karl Landsteiner University, 3500 Krems/Donau, Wing Y, KL Auditorium